Macular News

ARVO 2019: Neena Haider PhD

Harvard Medical SchoolSchepens Eye Research Institute of Massachusetts Eye and Ear Topic: Gut Biome In Relation to Eye Disease

ARVO 2019: Amir H. Kashani MD PhD

USC Roski Eye Institute Keck School of Medicine USC Topic: Stem-cell based therapy for dry AMD https://keck.usc.edu https://eye.keckmedicine.org/

ARVO 2019: Kimberly Gokoffski MD PhD

Assistant Professor of Clinical OphthalmologyUSC Roski Eye InstituteKeck Medicine of USCTopic: Electrical stimulation to regenerate the optic nerve re-establishing vision by connecting the eye to the brain

ARVO 2019: Praveen Gupta OD PhD

UTMB Health The University of Texas Medical Branch Topic: Histochemical Characterization of Drusen Related Pathology in Age Related Macular Degeneration

Harvard 2018: Jonathan B Lin

Washington University School of Medicine Apte Lab https://ophthalmology.wustl.edu/ Topic: Macrophage MicroRNA-150 Promotes Pathological Angiogenesis as seen in AMD

Harvard 2018: Anders Naar, PhD

University of California, Berkeley Metabolic Biology Department of Nutritional Sciences & Toxicology https://nst.berkeley.edu Topic: Cholesterol Lipid Regulation and AMD

Harvard 2018: Deborah Ferrington, PhD

Dept. of Ophthalmology and Visual Neurosciences University of Minnesota http://www.ophthalmology.umn.edu Topic: Mitochondrial dysfunction in the retinal pigment epithelium promotes AMD pathology

Harvard 2018: Andrew Dick, MD

Andrew Dick, MD Bristol Eye Hospital, University of Bristol http://www.bristol.ac.uk/medical-school/research/translational-health-sciences/ UCL Institute of Ophthalmology http://www.ucl.ac.uk Topic: Immunotherapy regulating immune responses through metabolic sensing

Harvard 2018: Joan W Miller, MD

Joan W Miller, MDProfessor of Ophthalmology – David Glendenning Cogan Chief of Ophthalmology – Mass Eye and Ear and Mass General HospitalChair, Dept. of Ophthalmology Harvard Medical School Topic: Current research on Early/Dry AMD

Harvard 2018: Goldis Malek PhD

Goldis Malek, PhD Duke Eye Center Duke University School of Medicine https://dukeeyecenter.duke.edu/research https://pathology.duke.edu/research/s… https://dukeeyecenter.duke.edu/about/… Presentation: Rethinking Nuclear Receptors as Therapeutic Targets for AMD

Harvard 2018: Aparna Lakkaraju PhD

Aparna Lakkaraju, PhD Department of Ophthalmology University of California, San Francisco http://ophthalmology.ucsf.edu/lakkara… Presentation: Intracellular Complement Activation in the Retinal Pigment Epithelium

ARVO 2018: Dr. Felicity de Cogan

EXCLUSIVE INTERVIEW: University of Birmingham Institute of Microbiology and Infection Royal Academy of Engineering Enterprise Fellow Topical treatment for AMD http://www.birmingham.ac.uk/microbiology-infection Presentation: Non-invasive delivery and efficacy of ranibizumab and bevacizumab in rabbit and porcine eyes MacRegen http://www.macregen.com

ARVO 2018: Nathan Hotaling PhD

Nathan Hotaling PhD National Eye Institute Biomaterials Group . Presentation: Training to Improve Precision and Accuracy in the Measurement of Fiber Morphology

ARVO 2018: Sudha Iyengar PhD

Sudha K. Iyengar PhD Professor – Vice Chair for Research Case Western Reserve University http://epbiwww.case.edu/ . Presentation: Identification of genes for Age-Related Macular Degeneration

ARVO 2018: Neena Haider PhD

Neena Haider PhD Associate Professor of Ophthalmology Harvard Medical School Schepens Eye Research Institute Massachusetts Eye and Ear . Presentation: Genetic modifier to ameliorate more than one form of inherited retinal degeneration & Unique genetic models to study the retinal and vascular phenotypes associated with AMD . http://www.masseyeandear.org http://www.schepens.harvard.edu/ http://www.hms.harvard.edu